Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02961907
Other study ID # P140934
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 22, 2018
Est. completion date January 12, 2021

Study information

Verified date December 2020
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Infertility is defined as the inability to conceive after 12 months of unprotected intercourse, It affects approximately one in six couples pregnancy. Many lifestyle factors of the couple's pre and peri-conceptional environment (weight, diet, alcohol, tobacco, coffee, drugs, exercise, stress, sleep, pollution...) are risk factors for infertility. Weight gain, in both members of the couple, is associated with an increased risk of Assisted Reproduction Technology (ART) failure and adverse pregnancy outcome, while healthy lifestyle makes the risk of infertility three times less likely to happen. Idiopathic infertility may greatly benefit from lifestyle factors optimization.


Description:

To evaluate and optimize periconceptional habits (diet and lifestyle factors) of unfertile couple may have favorable impact on conception and pregnancy. The investigators propose to undertake a controlled trial of the efficiency of an integrated global care program. This trial of an intervention on lifestyle factors will be compared with the ""cohort multiple randomised controlled trial"" methodology in order to strengthen external validity by limiting bias that may result from initial consent to randomisation, or from deception of allocated treatment. At any visit in a participating ART center, all attending couples will be invited to participate in an observational survey in order to allow access to their data. In this whole cohort, all eligible couples will be identified as consultations go. An ""on the fly"" randomisation process (ration 2 usual / 1 experimental) will select candidate couples from all eligible ones, who will be ten offered the experimental PEPCI intervention. In case of refusal of the experimental care, they will be given the usual care.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date January 12, 2021
Est. primary completion date October 20, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Couple attending a visit in an ART reproductive center (1st care regardless of the center regardless of the number of attempts in the center or in another center) - Heterosexual infertile couple (absence of pregnancy after 12 months of unprotected intercourse) - Men aged from 18 to 45 and women aged from 18 to 38 - Couple having not shown any opposition to the use of their data (observational study) and given their informed written consent to collect their biological samples - Couple with good understanding of the French language - Couple with computer equipment including webcam and internet access at home - Affiliation to the French health insurance organism - No-cons to the practice of adapted physical activity (non stabilized disease: diabetes, anemia, aplastic anemia, severe malnutrition, severe osteoporosis, heart or lung disease) - Signing of the informed consent form Exclusion Criteria: - BMI upper 40 for one or both members of the couple - Viral infection for one or both members of the couple (infection with HIV, Hepatitis B or C) - Ongoing pregnancy - One or both member of the couple medically treated for diabetes mellitus - One or both member of the couple medically treated for a psychotic disorder - Inability to comply with care program" - Couple already enroll in the study

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
PEPCI
Both parents will receive: consultation with a psychiatrist then psychologist follow-up if required, addiction specialist physician consultation then liaison nurse follow-up if required endocrinologist consultation then dietitian follow-up if required actiphysician consultation and follow-up if required This program will be added to the usual routine course Both parents will receive a 3 months personalized follow-up if required from the multi disciplinary consultation and before the first ART attempt.

Locations

Country Name City State
France Hôpital Tenon Paris

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical pregnancy will be obtained from evidence of gestational sac on ultrasound exam at 6 weeks of amenorrhea either after the first ART attempts 3 to 12 months after the initial visit
Secondary Percentage of refusal of PEPCI intervention 12 months and 10 months additional in case of pregnancy
Secondary Assessment of patient satisfaction according Satisfaction Questionnaire (CSQ) 12 months and 10 months additional in case of pregnancy
Secondary Assessment of impact on the health control according the Multidimensional Health Locus of Control Scale (french version) 12 months and 10 months additional in case of pregnancy
Secondary Assessment of weight using Body mass index (BMI) expressed in units of kg/m2 12 months and 10 months additional in case of pregnancy
Secondary Assessment of health risk associated with excess fat around the waist using Waist Circumference WC ( measured in centimeters) 12 months and 10 months additional in case of pregnancy
Secondary Assessment of physical activity according the International Physical Activity Questionnaire (IPAQ) 12 months and 10 months additional in case of pregnancy
Secondary Assessment of the quality and patterns of sleep according The Pittsburgh Sleep Quality Index (PSQI) 12 months and 10 months additional in case of pregnancy
Secondary Assessment of Anxiety and depressive disorders according Hospital Anxiety and Depression scale (HAD) 12 months and 10 months additional in case of pregnancy
See also
  Status Clinical Trial Phase
Completed NCT03607409 - Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
Recruiting NCT02312076 - GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles Phase 4
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Completed NCT03287479 - Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®) N/A
Terminated NCT03522350 - Randomized Trial Comparing EmbryoScope With EmbryoScope+. N/A
Completed NCT04496284 - Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen N/A
Completed NCT03623659 - pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts N/A
Completed NCT03895099 - New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors Phase 3
Active, not recruiting NCT04142112 - Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation N/A
Completed NCT03152643 - Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer N/A
Recruiting NCT03683771 - Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
Recruiting NCT03161119 - Comparing Two Different Embryo Transfer Catheters N/A
Completed NCT04108039 - Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. N/A
Completed NCT03677492 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD) N/A
Completed NCT03678818 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA) N/A
Completed NCT03678571 - Oocyte Vitrification Aided With Latrunculin A N/A
Completed NCT03678584 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA) N/A
Completed NCT03678597 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB) N/A
Completed NCT03678610 - Handling Medium for ICSI With Ionomycin and Latrunculin A N/A
Completed NCT03678558 - Oocyte Vitrification Aided With Cytochalasin B N/A